Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10
- 1 July 2003
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 76 (1) , 117-123
- https://doi.org/10.1016/s0003-4975(03)00194-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cytokine responses and myocardial injury in coronary artery bypass graftingScandinavian Journal of Clinical and Laboratory Investigation, 2001
- Perioperative Factors Influencing Interleukin-10 Release under Cardiopulmonary BypassThe Thoracic and Cardiovascular Surgeon, 1999
- Inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1998
- Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic TargetThe Journal of Clinical Pharmacology, 1998
- Pulmonary Effects of Methylprednisolone in Patients Undergoing Coronary Artery Bypass Grafting and Early Tracheal ExtubationAnesthesia & Analgesia, 1998
- Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patientsAmerican Heart Journal, 1997
- Cytokine Responses to Cardiopulmonary Bypass: Lessons Learned From Cardiac TransplantationThe Annals of Thoracic Surgery, 1997
- The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failureThe American Journal of Surgery, 1996
- IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cellsImmunology Letters, 1995
- Antegrade/Retrograde Blood Cardioplegia to Ensure Cardioplegic Distribution: Operative Techniques and ObjectivesJournal of Cardiac Surgery, 1989